What Is Adipotide? Dosage, Half-Life & How to Track It
Also known as: FTPP (fat-targeted proapoptotic peptide) · Prohibitin-targeting peptide
Adipotide is a peptidomimetic designed to destroy the blood supply to fat tissue — it targets a receptor called prohibitin on blood vessels in white adipose tissue and delivers a cell-death signal, starving fat cells of blood flow. Preclinical trials in obese primates showed real weight loss, but human Phase 1 development was discontinued over kidney-toxicity concerns. Research dosing runs a cautious daily titration from 250 mcg up to 1,000 mcg. This is one of the higher-risk compounds in this library — educational information only.
What Adipotide is and how it works
Adipotide is a peptidomimetic — a lab-designed molecule that mimics a peptide’s binding behavior — engineered to target prohibitin, a protein expressed on the blood vessels that supply white adipose tissue specifically. Attached to that targeting piece is a pro-apoptotic (cell-death-triggering) sequence: once bound, it signals those blood vessels to die.
The logic is mechanically different from every appetite- or metabolism-based compound in this library: Adipotide doesn’t suppress hunger or boost fat-burning — it starves fat tissue of its blood supply directly, and fat cells die off as a downstream consequence of losing circulation. Preclinical studies in obese rodents and primates showed genuinely notable weight loss through this mechanism.
The critical fact to know before anything else: human Phase 1 clinical development was discontinued after safety concerns emerged, specifically around renal (kidney) toxicity at effective doses. Unlike the other investigational compounds here, this isn’t just “not yet approved” — it’s a compound whose human trial was stopped for a safety signal. That materially changes the risk calculus.
Typical dosing & reconstitution
Research protocols use a slow, conservative escalation specifically because of the renal-toxicity signal from preclinical work:
- Weeks 1–2: 250 mcg once daily
- Weeks 3–4: 500 mcg once daily
- Weeks 5–6: 750 mcg once daily
- Weeks 7–8: 1,000 mcg once daily
| Vial | BAC water | Concentration | 1 unit (U-100) ≈ |
|---|---|---|---|
| 10 mg | 3 mL | 3.33 mg/mL | 33.3 mcg |
This uses the largest practical dilution specifically to keep early doses in a readable unit range and to support the conservative, slow escalation the safety data calls for — a faster ramp isn’t a shortcut worth taking given why the compound’s human trial was halted.
Half-life & what it means for frequency
Adipotide doesn’t have a well-characterized human pharmacokinetic profile — the clinical program that would have established one was discontinued early. Research protocols default to once-daily subcutaneous dosing, consistent with how it behaves in the preclinical literature, rather than a number derived from human trials.
That gap in the data is itself important context: for most compounds in this library, the open question is how to dose optimally within a known safety profile. For Adipotide, part of the safety profile itself was never fully established in humans.
What to track & common side effects
The signal that matters most is renal function — the reason clinical development stopped was kidney-toxicity risk that emerged at effective doses in the Phase 1 trial. Anyone researching this compound should treat kidney-function monitoring as non-negotiable, not optional.
Beyond that, the general daily-peptide tracking logic applies: dose, streak, and any physical marker you’re watching — but with Adipotide specifically, the renal-safety question should be the first thing tracked and taken seriously, well ahead of weight or fat-loss metrics.
How to track Adipotide in Stackeddd
If tracking Adipotide, log every dose precisely and treat kidney-function monitoring as the priority metric, not an afterthought — that’s the specific signal that ended its human clinical program. The conservative, slow titration above exists because of that safety data; logging keeps you honest about actually following it.
Model it yourself · free, no account
Reconstitution Calculator
Model it yourself: enter your vial size and BAC water and the Peptides tab returns concentration and exact units for any dose — the same math built into the Stackeddd app.
Related compounds
Related reading: Peptide reconstitution math: how much BAC water to add
Frequently asked questions
What is Adipotide used for?
It’s a peptidomimetic studied for targeted fat loss — it binds prohibitin on blood vessels in white adipose tissue and triggers those vessels to die, cutting off blood supply to fat cells. Preclinical trials in obese animals showed real weight loss.
Is Adipotide safe?
This is the compound to be most cautious about in this library. Human Phase 1 development was discontinued due to kidney-toxicity concerns at effective doses — it is not simply "unapproved," it has a documented safety signal from its own clinical trial.
What is the half-life of Adipotide?
Not well characterized in humans, since the clinical trial that would have established a full pharmacokinetic profile was stopped early. Research protocols use once-daily dosing based on preclinical behavior.
How is Adipotide dosed in research protocols?
A conservative titration starts at 250 mcg once daily, increasing by 250 mcg every two weeks up to 1,000 mcg — a deliberately slow ramp given the renal-toxicity signal from its clinical history.
This is educational information, not medical advice. Doses and protocols above reflect published references and community practice — protocol decisions belong with your prescribing physician. Generic names used throughout. How this reference is built & how the AI is tested →
STACKEDDD
Track it instead of guessing.
Doses, reconstitution, bloodwork, and an AI coach grounded in your own data — free to start, on the App Store and Google Play.